Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Zanco Journal of Medical Sciences. 2016; 20 (1): 1186-1198
en Inglés | IMEMR | ID: emr-184169

RESUMEN

Background and objective: Impaired wound healing is a major complication of diabetes mellitus. This study was carried out to determine the healing process of oral mucosa in diabetic rats and the role of systemic tumor necrosis factor alpha inhibitor [infliximab]


Methods: Thirty eight male rats were divided into two groups, the normoglycemic group [11 rats], and diabetic group [27 rats] that were rendered diabetic by alloxan injection. Two months later, wound was created in the lateral side of the tongue for both groups. The diabetic group was then subdivided into two subgroups, 14 rats received 5mg/kg infliximab subcutaneous injection at the day of wound creation while the other 13 rats received saline injection. After 7 days, biopsies of the tongue were collected and subjected to histological and histochemical procedure


Results: Histological examinations showed delayed healing in the diabetic group with persistence of epithelial discontinuity, large amount of granulation tissue and destruction of the underlying muscle fibers. In the subgroup injected with infliximab, reepitheliazation of the wound was demonstrated with well arranged underlying collagen fibers. Using PAS stain, diabetic group revealed a dramatically high amount of PAS positive precipitants in the lamina properia, especially in the wall of the blood vessels, while with infliximab injection, the PAS+ve precipitants were more prominent than normoglycemic group but less than diabetic group without infliximab


Conclusion: These findings suggest that infliximab accelerated mucosal wound healing in the diabetic rats with the formation of well organized connective tissue

2.
Zanco Journal of Medical Sciences. 2016; 20 (2): 1337-1348
en Inglés | IMEMR | ID: emr-184515

RESUMEN

Background and objective: Orthodontic tooth movement is mediated by tumor necrosis factor -alpha through activation of osteoclasts. Type 1 diabetes mellitus is characterized by a change in the bone remodeling and affects orthodontic treatment. This study aimed to investigate the effects of infliximab local injection on orthodontic movement in the diabetic rabbit


Methods: Sixty six rabbits were divided equally into three groups; two groups were rendered diabetic using alloxan injection, while the third group was regarded as a normoglycemic group. Only one of the diabetic groups received insulin treatment. All rabbits were subjected to orthodontic tooth movement of upper central incisor for 18 days, half of each group received infliximab subperiosteal injection, while the remaining number received saline injection. After sacrifice, tissue samples were subjected to histological preparation and histomorphometric analysis


Results: Insulin treated group revealed less prominent destruction of the periodontium when compared with the untreated group. The histological pictures of infliximab injected groups demonstrated less bone resorption in pressure side and more bone formation in tension side. There was a significantly smaller number of osteoclast with less compression in the width of the periodontal ligament in the tension side with infliximab injection


Conclusion: Infliximab local injection hindered bone resorption in the diabetic state during orthodontic tooth movement

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA